BioWorld17m
Medtronic sees SMART TAVR results in small aortic annulus patients
Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...
TCTMD4h
SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years
The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...
MassDevice10h
Medtronic’s SMART trial shows positive Evolut TAVR performance in small aortic annulus patients
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Medical Xpress14d
New drug shows promise in reducing aortic valve surgeries
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...